Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE−/− mice

Abstract

These results have demonstrated that BBR derivatives, dhBBR and Di-MeBBR, are superior to BBR in inhibiting inflammation and reducing plaque size and vulnerability.